NASDAQ: BEAM - Beam Therapeutics Inc.

Rentabilidade por seis meses: -17.78%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Beam Therapeutics Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Beam Therapeutics Inc.

Биотехнологическая компания Beam Therapeutics Inc. занимается разработкой высокоточных генетических лекарств для пациентов, страдающих серьезными заболеваниями в Соединенных Штатах. Компания разрабатывает методы лечения серповидно-клеточной анемии и бета-талассемии; CAR-T-клеточная терапия острого лимфобластного лейкоза у детей и острого миелоидного лейкоза у детей; терапии дефицита альфа-1-антитрипсина и нарушения накопления гликогена 1А; и лечение заболеваний глаз и центральной нервной системы.

mais detalhes
Компания имеет соглашение о сотрудничестве в области исследований и клинической практики с Magenta Therapeutics, Inc. Компания Beam Therapeutics Inc. была основана в 2017 году и базируется в Кембридже, штат Массачусетс.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2020-02-06
ISIN US07373V1052
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.beamtx.com
Цена ао 26.39
Alteração de preço por dia: -1.18% (26.29)
Alteração de preço por semana: +10.84% (23.44)
Alteração de preço por mês: -9.82% (28.81)
Alteração de preço em 3 meses: +20.56% (21.55)
Mudança de preço em seis meses: -17.78% (31.6)
Mudança de preço por ano: +6.96% (24.29)
Mudança de preço em 3 anos: -59.16% (63.61)
Mudança de preço em 5 anos: +49.48% (17.38)
Mudança de preço em 10 anos: 0% (25.98)
Mudança de preço desde o início do ano: -6.98% (27.93)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 6.09 1
P/BV 2.34 6
P/E 0 0
EV/EBITDA -13.02 0
Total: 4.13

Eficiência

Nome Significado Nota
ROA, % -9.08 0
ROE, % -13.5 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -1.11 10
Total: 9.4

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 2098283.33 10
Rentabilidade Ebitda, % 126.12 10
Rentabilidade EPS, % -7.15 0
Total: 7.4
Mais detalhes

Data da transação Data de divulgação Insider Tipo Preço Volume Quantidade Compartilhe até, % Compartilhe depois, % Documento
31.12.2024 30.12.2024 CHRISTINE BELLON
Officer		 Comprar 25.27 105 300 4167 0 0.01 link
31.12.2024 30.12.2024 BETHANY J. CAVANAGH
Officer		 Comprar 25.27 240 065 9500 0 0.01 link
02.07.2024 03.07.2024 Simon Amy
Chief Medical Officer		 Oferta 22.95 17 167 748 0 0 link
01.07.2024 03.07.2024 Simon Amy
Chief Medical Officer		 Oferta 23.76 11 928 502 0 0 link
27.06.2024 28.06.2024 Evans John M.
CEO		 Oferta 24.5 1 470 000 60000 0 -0.09 link
28.03.2024 01.04.2024 Evans John M.
CEO		 Oferta 33.86 2 031 600 60000 0 -0.09 link
14.02.2024 15.02.2024 FMR LLC
See Remark 1		 Oferta 30.55 27 495 000 900000 0 -1.32 link
13.02.2024 15.02.2024 FMR LLC
See Remark 1		 Oferta 30.76 48 139 1565 0 0 link
31.03.2023 31.03.2023 Evans John M.
CEO		 Comprar 7.22 99 997 13850 0 0.02 link
30.03.2023 31.03.2023 Bellon Christine
Chief Legal Officer		 Comprar 7.22 64 554 8941 0 0.01 link
13.04.2022 14.04.2022 FMR LLC
See Remark 1		 Oferta 50.41 981 281 19466 0 -0.03 link
31.03.2022 04.04.2022 Burrell Terry-Ann
CFO		 Oferta 59.11 105 630 1787 0 0 link
22.12.2021 23.12.2021 Ciaramella Giuseppe
President & CSO		 Oferta 86.13 224 541 2607 0 0 link
22.12.2021 23.12.2021 Ciaramella Giuseppe
President & CSO		 Comprar 7.22 18 823 2607 0 0 link
21.12.2021 22.12.2021 Ciaramella Giuseppe
President & CSO		 Oferta 85.69 2 151 160 25104 0 -0.04 link
21.12.2021 22.12.2021 Ciaramella Giuseppe
President & CSO		 Comprar 7.22 181 251 25104 0 0.04 link
20.12.2021 22.12.2021 Ciaramella Giuseppe
President & CSO		 Oferta 85.2 365 423 4289 0 -0.01 link
20.12.2021 22.12.2021 Ciaramella Giuseppe
President & CSO		 Comprar 7.22 30 967 4289 0 0.01 link

Instituições Volume Compartilhar, %
ARK Investment Management, LLC 9393889 11.5
Vanguard Group Inc 7164876 8.77
Blackrock Inc. 6662043 8.16
FMR, LLC 6180322 7.57
State Street Corporation 4616358 5.65
Morgan Stanley 4184342 5.12
Farallon Capital Management Llc 4105753 5.03
Temasek Holdings (Private) Limited 3076117 3.77
Sumitomo Mitsui Trust Holdings, Inc. 2358091 2.89
Nikko Asset Management Americas, Inc. 2358091 2.89

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
ARK Genomic Revolution ETF 3.63493 -8.08 0.05494
Direxion Fallen Knives ETF 3.32 49.48 6.08
Global X Genomics & Biotechnology ETF 3.0157 2.58 0.15585
ARK Innovation ETF 2.11301 34.1 0.00666
WisdomTree BioRevolution Fund 1.09862 -4.69 0.78691
Jacob Forward ETF 0.99099 43.03 0.15284
Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund 0.87675 1.54 0.22433
Virtus LifeSci Biotech Clinical Trials ETF 0.80513 63.04 0.33
IQ Healthy Hearts ETF 0.49956 16.74 1.95958
Direxion Daily S&P Biotech Bull 3x Shares 0.35522 4067.92 0.25924
First Trust Nasdaq Pharmaceuticals ETF 0.31005 18.37 2.19901
Invesco Nasdaq Biotechnology ETF 0.20678 28.58 0.8565
Avantis U.S Small Cap Equity ETF 0.20676 27.77 1.68271
Future Tech ETF 0.20482 426.34 0.8416
Principal Healthcare Innovators ETF 0.20482 618.5 0.8416
Vanguard Russell 2000 Value ETF 0.15 12.26 2.37825
ProShares Ultra Nasdaq Biotechnology 0.13948 51.7 0.85651
First Trust Small Cap Growth AlphaDEX Fund 0.12166 42.5 1.22182
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.12166 24.75 1.59225
SPDR S&P Kensho New Economies Composite ETF 0.10265 21.57 0.88486
BNY Mellon US Small Cap Core Equity ETF 0.10182 30.07 1.75333
Goldman Sachs Innovate Equity ETF 0.08187 29.66 1.20987
Vanguard Russell 2000 ETF 0.08 17.16 1.48801
iShares Morningstar Small Cap Value ETF 0.07987 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.07987 201.65 2.50476
iShares ESG Aware MSCI USA Small-Cap ETF 0.04961 18.09 1.49366
Schwab U.S. Small-Cap ETF 0.04639 17.47 1.51433
ProShares UltraPro Russell2000 0.04237 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.03904 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.03904 391.25 1.60498
iShares U.S. Tech Breakthrough Multisector ETF 0.03656 21.8 0.73986
FlexShares Morningstar US Market Factor Tilt Index Fund 0.02941 21.94 1.69572
Fidelity MSCI Health Care Index ETF 0.02672 3 1.46057
First Trust Multi Cap Growth AlphaDEX Fund 0.02588 41.56 1.02425
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02264 17.58 1.75869
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.02171 31.36 1.41955
Dimensional U.S. Core Equity 2 ETF 0.01389 30.76 1.47098
ProShares Hedge Replication ETF 0.0119 5.92 1.47892
Humankind US Stock ETF 0.00847 18.81 1.99919
Dimensional US Core Equity Market ETF 0.00441 30.98 1.40618
iShares Russell 3000 ETF 0.00369 24.83 1.43482
Avantis U.S. Equity ETF 0.00354 23.04 1.59151
Schwab U.S. Broad Market ETF 0.00324 24.86 1.43354
Dimensional U.S. Equity ETF 0.00287 31.53 1.3557
SPDR Portfolio MSCI Global Stock Market ETF 0.00261 17.99 2.19607
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927
Vanguard Russell 3000 ETF 0 31.87 1.43817
Convergence Long/Short Equity ETF -0.17977 32.85 1.56428



Supervisor Cargo Pagamento Ano de nascimento
Mr. John M. Evans M.B.A. CEO & Director 1.11M 1978 (47 anos)
Dr. David R. Liu Ph.D. Co-Founder N/A
Dr. Giuseppe Ciaramella Ph.D. President 933.2k 1969 (56 anos)
Dr. J. Keith Joung M.D., Ph.D. Co-Founder N/A
Dr. Feng Zhang Ph.D. Co-Founder N/A
Dr. Manmohan Singh Ph.D. Chief Technology Officer N/A
Dr. Gopi Shanker Ph.D. Chief Scientific Officer N/A
Dr. Christine P. Bellon J.D., Ph.D. Senior VP, Chief Legal Officer & Corporate Secretary 1966 (59 anos)
Dr. Amy Simon M.D. Chief Medical Officer 1964 (61 ano)
Bethany J. Cavanagh Senior VP of Finance & Treasurer

Endereço: United States, Cambridge, MA , 26 Landsdowne Street - abrir no Google Maps, abrir mapas Yandex
Site: http://www.beamtx.com